We are live on ! Find out more
EBS icon

Emergent Biosolutions

162 hedge funds and large institutions have $629M invested in Emergent Biosolutions in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 57 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

1.73% more ownership

Funds ownership: 77.92%79.65% (+1.7%)

1% more funds holding

Funds holding: 160162 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 57

4% less capital invested

Capital invested by funds: $655M → $629M (-$25.3M)

Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.7%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
57
Reduced
57
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
101
State Board of Administration of Florida Retirement System
Florida
$453K
AI
102
Analytic Investors
California
$451K -$54.7K -2,389 -10%
MLICM
103
Metropolitan Life Insurance Company (MetLife)
New York
$450K
ASRS
104
Arizona State Retirement System
Arizona
$432K
New York State Teachers Retirement System (NYSTRS)
105
New York State Teachers Retirement System (NYSTRS)
New York
$412K +$2.29K +100 +0.5%
Asset Management One
106
Asset Management One
Japan
$399K -$301K -13,137 -41%
US Bancorp
107
US Bancorp
Minnesota
$385K +$65.8K +2,872 +19%
ARTA
108
A.R.T. Advisors
New York
$372K +$400K +17,466 New
PP
109
PDT Partners
New York
$364K -$163K -7,104 -29%
SKK
110
Shepherd Kaplan Krochuk
Massachusetts
$356K +$30.7K +1,340 +9%
Royal Bank of Canada
111
Royal Bank of Canada
Ontario, Canada
$352K -$77K -3,363 -17%
ECM
112
ETrade Capital Management
Virginia
$349K +$375K +16,383 New
Wells Fargo
113
Wells Fargo
California
$340K -$35K -1,529 -9%
Millennium Management
114
Millennium Management
New York
$335K +$146K +6,384 +69%
Nisa Investment Advisors
115
Nisa Investment Advisors
Missouri
$330K -$22.9K -1,000 -6%
BPGAM
116
BTG Pactual Global Asset Management
Bermuda
$327K
PCM
117
Piermont Capital Management
Missouri
$327K +$351K +15,350 New
Fifth Third Bancorp
118
Fifth Third Bancorp
Ohio
$300K -$124K -5,416 -28%
CAM
119
Capstone Asset Management
Texas
$297K
LSERS
120
Louisiana State Employees Retirement System
Louisiana
$286K -$6.87K -300 -2%
HCM
121
Highbridge Capital Management
New York
$278K -$551K -24,075 -65%
MC
122
Miles Capital
Iowa
$268K
ProShare Advisors
123
ProShare Advisors
Maryland
$261K -$69.3K -3,026 -20%
Creative Planning
124
Creative Planning
Kansas
$256K +$260K +11,360 +1,775%
GMIM
125
General Motors Investment Management
New York
$253K

EBS Hedge Fund Activity: Q3 2014 in Review

162 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2014, worth a combined $629M — down 3.9% from $655M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new EBS positions and 14 closed out — a net gain of 2 holders — while 57 added to existing stakes and 57 trimmed.

The largest buyer was Fiduciary Management Associates, opening a new position worth an estimated $14.9M. The largest seller was Numeric Investors, exiting entirely with an estimated $14.3M sold.

  • 162 institutional investors held Emergent Biosolutions (EBS) as of Q3 2014, up from 160 in Q2 2014.
  • Funds reported $629M of Emergent Biosolutions stock for Q3 2014, down 3.9% quarter-over-quarter.
  • 16 funds opened new Emergent Biosolutions positions in Q3 2014 and 14 closed out, a net change of +2 holders.
  • The largest Emergent Biosolutions buyer in Q3 2014 was Fiduciary Management Associates, an estimated $14.9M added.
  • The largest Emergent Biosolutions seller in Q3 2014 was Numeric Investors, an estimated $14.3M sold.

Based on aggregated 13F filings for Q3 2014.